ECZEMA, PSORIASIS & DERMATITIS MANAGEMENT

The Clinical Picture

1

Chronic inflammatory skin conditions are complex medical issues driven by immune system dysregulation and defects in the physical skin barrier. They are not merely "dry skin" and cannot be treated with cosmetic moisturisers

  • Atopic Eczema: Fundamentally a defect in the skin barrier (often due to a lack of the protein Filaggrin). This allows moisture to escape (Trans-Epidermal Water Loss) and allergens to enter, triggering a chronic itch-scratch cycle and inflammation.

  • Psoriasis: An autoimmune condition where the immune system attacks healthy skin cells by mistake. This causes rapid cell turnover (every 3-4 days instead of 28), leading to the build-up of thick, scaly plaques, usually on the elbows, knees, and scalp.

  • Seborrhoeic Dermatitis: An inflammatory reaction to the Malassezia yeast which naturally lives on everyone's skin. In susceptible patients, the immune system overreacts to this yeast, causing red, scaly, and greasy patches in areas rich in oil glands (scalp, eyebrows, nasolabial folds).

Our Medical Approach

2

Success begins with accurate diagnosis. We frequently see patients treating “dry skin" who actually have fungal dermatitis. As GPs, we see and treat the vast majority of dermatology conditions in the community, and have a wealth of experience, training and examinations behind us.

Our protocol involves a “ladder" of intervention: identifying triggers, repairing the barrier with medical emollients, and suppressing flares with prescription agents.

We do not offer “cures",we offer effective, long-term medical management strategies.

Clinical Solutions

3

GP Dermatology Consultation:

A dedicated 45-minute medical assessment to diagnose the specific dermatosis and review your medical history.

Prescription Management:

Access to prescription-strength steroids, calcineurin inhibitors, and antifungals (e.g., Ketoconazole) where clinically indicated.

Barrier Repair Protocols:

Clinically proven emollient therapy to restore the stratum corneum.

Long-term steroid use can thin the skin. Our safety protocol focuses on "Steroid Sparing" strategies-using the minimum effective dose for the shortest time, and transitioning to non-steroidal maintenance therapies. We also screen for infection risks which are higher in compromised skin